Kaynaklar

• Tractenberg RE, Singer CM, Cummings JL, Thal LJ. The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease. J Sleep Res 2003; 12(4):331–7.
   PubMed Web of Science ®Google Scholar
• Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R. Predictors of institution alization for people with dementia living at home with a carer. Int J Geriatr Psychiatry 1998; 13(10):682–90.
   PubMed Web of Science ®Google Scholar
• McCurry SM, Reynolds CF, Ancoli-Israel S, Teri L, Vitiello MV. Treatment of sleep disturbance in Alzheimer's disease. Sleep Med Rev 2000; 4(6):603–28.
   Web of Science ®Google Scholar
• Bomboıs S, Derambure P, Pasquıer F, Monaca C. Sleep disorders in aging and dementia. J Nutr Health Aging 2010; 14(3):212–7.
   PubMed Web of Science ®Google Scholar
• Ross JS, Shua-Haim JR. Aricept-induced nightmares in Alzheimer's disease: 2 case reports. Am J Geriatr Soc 1998; 46(1):119–20.
   PubMed Web of Science ®Google Scholar
• Kitabayashi Y, Ueda H, Tsuchida H, Yamashita T, Narumoto J, Fukui K. Donepezil-induced nightmares in mild cognitive impairment. Psychiatry Clin Neurosci 2006; 60(1):123–4.
   Web of Science ®Google Scholar
• Nieoullon A, Bentue-Ferrer D, Bordet R, Tsolaki M, Forstl H. Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine. Curr Med Res Opin 2008; 24(12):3357–67.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association, Diagnostic and Statistical Manual of mental Disorders. 4th ed. 2000, revised. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Mc Khann G, Drachman D, Folstein M, Katzman R, Price D. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS- ADRDA Work Group under the auspices of Department og Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34(7):939–44.
   Web of Science ®Google Scholar
• Gold G, Giannakopoulos P, Montes-Paixao JC. Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997; 49(3):690–4.
   Web of Science ®Google Scholar
• McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65(12):1863–72.
   PubMed Web of Science ®Google Scholar
• Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22(12):1689–707.
   PubMed Web of Science ®Google Scholar
• Güngen C. Standardize Mini Mental Testin Türk Yaşlı Popülasyonunda Demansiyel Sendromların Tanınmasında Eğitim Düzeylerine Göre Geçerlilik ve Güvenilirliğinin İncelenmesi. Yayımlanmamış Uzmanlık Tezi, İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Psikiyatri AD, İstanbul, 1999.
   Google Scholar
• Deschenes CL, McCurry SM. Current Treatments for Sleep Disturbances in Individuals With Dementia Curr. Psychiatry Rep 2009; 11(1):20–6.
   PubMed Web of Science ®Google Scholar
• Wu YH, Swaab DF. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Med 2007; 8(6):623–36.
   PubMed Web of Science ®Google Scholar
• Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med 2005; 6(4):347–52.
   PubMed Web of Science ®Google Scholar
• Ancoli-Israel S, Klauber MR, Gillin JC, Campbell SS, Hofstetter CR. Sleep in noninstitutionalized Alzheimer's disease patients. Aging (Milano) 1994; 6(6):451–8.
   Google Scholar
• Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med 2007;8(Suppl 4):S27–S34.
   Google Scholar
• Bhatt MH, Podder N, Chokroverty S. Sleep and neurode-generative disorders. Semin Neurol 2005; 25(1):39–51.
   Google Scholar
• Wu YH, Swaab DF. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer's disease. Sleep Medicine 2007; 8(6):623–36.
   PubMed Web of Science ®Google Scholar
• Iraqi A, Hughes TL. An unusual case of nightmares with galantamine. J Am Geriatr Soc 2009; 57(3):565.
   Web of Science ®Google Scholar
• Stahl SM, Markowitz JS, Gutterman EM, Papadopoulos G. Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community. J Clin Psychiatry 2003; 64(4):466–72.
   Web of Science ®Google Scholar
• Nieoullon A, Bentue-Ferrer D, Bordet R, Tsolaki M, Forstl H. Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine. Curr Med Res Opin 2008; 24(12):3357–67.
   PubMed Web of Science ®Google Scholar
• Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S. Brain levels and acetylcholinesterease inhibition with galantamine and donepezil in rats, mice, and rabbits. Brain Res 2005; 1033(2):186–93.
   Web of Science ®Google Scholar
• Basta M, Chrousos GP, Vela-Bueno A, Vgontzas AN. Chronic insomnia and stress system. Sleep Med Clin 2007; 2(2):279–91.
   PubMedGoogle Scholar
• Conrad CD, Bimonte-Nelson HA. Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline. Prog Brain Res 2010; 182:31–76.
   PubMed Web of Science ®Google Scholar
• Turan T, Izgi HB, Ozsoy S, Tanrıverdi F, Basturk M, Asdemir A, et al. The Effects of Galantamine Hydrobromide Treatment on Dehydroepiandrosterone Sulfate and Cortisol Levels in Patients with Chronic Fatigue Syndrome. Psychiatry Investig 2009; 6(3):204–10.
   Web of Science ®Google Scholar
• Uluoğlu C, Güney HZ. Demanslı yaşlı hastalar üzerinde yapılan ilaç araştırmaları. Türk Geriatri Dergisi 2010;13(Suppl 3):61–9.
   Google Scholar
• Wirz-Justice A, Werth E, Savaskan E, Knoblauch V, Gasio PF, Muller-Spahn F. Haloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer disease. Alzheimer Dis Assoc Disord 2000; 14(4):212–5.
   PubMed Web of Science ®Google Scholar